The PE Ratio as of April 2025 (TTM) for Futura Medical plc (FAMDF) is 9.00

According to Futura Medical plc’s latest financial reports and current stock price. The company's current PE Ratio is 9.00. This represents a change of -418.10% compared to the average of -2.83 of the last 4 quarters.

Futura Medical plc (FAMDF) Historical PE Ratio (quarterly & annually)

How has FAMDF PE Ratio performed in the past?

The mean historical PE Ratio of Futura Medical plc over the last ten years is -12.03. The current 9.00 PE Ratio has changed -7578.62% with respect to the historical average. Over the past ten years (40 quarters), FAMDF's PE Ratio was at its highest in in the June 2024 quarter at 28.24. The PE Ratio was at its lowest in in the June 2023 quarter at -24.64.

Futura Medical plc (FAMDF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Futura Medical plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Futura Medical plc (FAMDF) Average PE Ratio

How has FAMDF PE Ratio performed in the past?

The current PE Ratio of Futura Medical plc (FAMDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Futura Medical plc (FAMDF) PE Ratio vs. Peers

How is FAMDF’s PE Ratio compared to its peers?

Futura Medical plc’s PE Ratio is greater than Pliant Therapeutics, Inc. (-0.42), greater than REGENXBIO Inc. (-1.33), greater than Immunocore Holdings plc (-27.83), less than Protagonist Therapeutics, Inc. (10.35), greater than Revolution Medicines, Inc. (-10.28), greater than Neoleukin Therapeutics, Inc. (-5.86), greater than CytomX Therapeutics, Inc. (1.74), greater than Assembly Biosciences, Inc. (-1.50), greater than Instil Bio, Inc. (-1.36), greater than Nuvation Bio Inc. (-1.17), greater than Sigilon Therapeutics, Inc. (-16.76), greater than NovaBay Pharmaceuticals, Inc. (-0.30), greater than InMed Pharmaceuticals Inc. (-0.00), greater than GeoVax Labs, Inc. (-0.19), greater than Phio Pharmaceuticals Corp. (-1.69), greater than Spero Therapeutics, Inc. (-0.59), greater than NextCure, Inc. (-0.18), greater than Kymera Therapeutics, Inc. (-9.28), greater than C4 Therapeutics, Inc. (-0.84), greater than Agios Pharmaceuticals, Inc. (2.33), greater than Nurix Therapeutics, Inc. (-4.11),

Build a custom stock screener for Futura Medical plc (FAMDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Futura Medical plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Futura Medical plc (FAMDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Futura Medical plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.